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Optic Pathway Glioma (OPG) is a relatively common brain tumour in childhood; however, there is 
scarce understanding of neuropsychological sequelae in these survivors. In this study, 12 children with 
diagnosis of OPG before 6 years of age received a comprehensive standardised assessment of visual 
perception, general intelligence and academic achievement, using adjustments to visual materials of 
the tests, to examine the extent of concurrent impairment in these functional domains. Information 
about vision, clinical and socio-demographic factors were extracted from medical records to assess the 
associations of neuropsychological outcomes with clinical and socio-demographic factors. Children 
with OPG exhibited high within-patient variability and moderate group-level impairment compared 
to test norms. Visual perception was the most impaired domain, while scholastic progression was age-
appropriate overall. For cognition, core verbal and visuo-spatial reasoning skills were intact, whereas 
deficits were found in working memory and processing speed. Visual function was associated with tasks 
that rely on visual input. Children with OPG are at moderate risk of neuropsychological impairment, 
especially for visual perception and cognitive proficiency. Future research should elucidate further the 
relative contribution of vision loss and neurofibromatosis type 1 co-diagnosis within a large sample.
Optic Pathway Gliomas (OPGs) represent about 5% of all intracranial neoplasms in childhood1,2. They are a 
relatively homogeneous group of benign lesions that arise in any structure along the visual pathway and histolog-
ically classify as pilocytic astrocytoma. Half or more OPGs are associated with Neurofibromatosis type 1 (NF1)3,4, 
a multisystem genetic disorder that is associated with neuropsychological sequelae, including mild intellectual 
impairment, inattention, visuospatial deficits and learning disability5–9. While survival rates of OPG exceed 90%10, 
most children experience some degree of visual impairment that significantly affects their quality of life11,12.
Both NF1 comorbidity and visual impairment place children with OPG at risk of neuropsychological difficul-
ties, but research has rarely focused on functional outcomes beyond vision. Retrospective investigations of OPG 
survivorship at two large north American institutions showed that only 26% to 42% of the whole patients cohort 
received sufficient psychological evaluation, and they reported only broad measures of Intelligence Quotient 
(IQ)13, in a descriptive manner10. One prospective study14 documented the neuropsychological profile of 21 
school-aged children with OPG initially treated with chemotherapy integrating an IQ test for cognitive function 
with a collection of subtests from different batteries for individual perceptual and scholastic skills. This study was 
limited by the fact that over a third of the children had been treated with additional radiotherapy, the most critical 
risk factor for neurocognitive decline15,16. In addition, this does not reflect the modern approach to OPG manage-
ment, which involves chemotherapy alone for cases requiring treatment17. In line with this, another prospective 
study18 evaluated 8 children with OPG (with hypothalamic involvement) before and after chemotherapy, but 
outcome measures included only IQ and executive functions tested through a variety of batteries. Finally, within 
the NF1 literature, children with diagnosed or treated OPG have typically been excluded from neuropsychology 
studies5,6,19, whereas the very few studies that attempted to disentangle the relative contribution of NF1 and brain 
tumour did not always focus on OPG20–22.
Although small sample size is an inherent limitation of research within this relatively rare condition, drawing 
conclusions from the available literature is hindered by problems with the analyses. When conducted10, statistical 
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analyses consisted of between- or within-group comparisons involving two or more conditions or timepoints, 
without adopting multiple testing corrections14,18. For example, Lacaze et al14. compared 21 school-aged children 
dividing them into three subgroups based on NF1 status and treatment type, whereas Riva et al18. compared IQ 
scores before and after chemotherapy in 8 children. Furthermore, comparisons were conducted at the level of sin-
gle subtests, whose examination is typically recommended only for within-subject analyses and individual profile 
description;23 indeed, pinpointing to such specific impairments to characterise a clinical population is prob-
lematic with small samples. Conversely, group means of broader indices have been reported only in descriptive 
manner10,14, without taking advantage of the possibility offered by standardised assessments to compare group 
means with the test normative mean. Finally, a further limitation is that none of the above studies stated whether 
adaptations to standardised assessment were used to address the visual impairment possibly experienced by these 
patients, as recommended by the recent European guidelines for assessing quality of survival in childhood brain 
tumour trials24.
The current study advances on previous research by investigating long-term outcomes on several neuropsy-
chological domains in a group of patients who are representative of an OPG cohort treated and assessed follow-
ing recent protocols. Specifically, this study integrates the assessment of general intelligence with two additional 
domains, namely scholastic attainment and visual perception. First, research on childhood brain tumour suggests 
that working memory, attention span, and in particular processing speed are the most affected domains25,26 and 
significantly impact on scholastic development27–30. Which cognitive and academic skills are affected in children 
with OPG and how they are interrelated has not yet been investigated. Second, the domain of visual perception 
is highly relevant due not only to the nature of OPG, which affects the visual system, but also for NF1 comorbid-
ity, that is characterised by visuo-perceptual deficits6,31 even with normal IQ32. For these reasons, investigation 
of visual perception in the OPG population requires a clear construct definition33 that has not been provided 
in previous research14. According to hierarchical models of visual processing, visual perception is the ability to 
process physical features of visual stimuli, hence it is the intermediate level between sensation (i.e., the automatic 
reaction of the receptor cells, for example visual acuity) and cognition (i.e., the elaboration of abstract and sym-
bolic properties, for example reading)34. Studies on children with typical development and with cancer history 
suggest that visuoperceptual and visual-motor skills support the acquisition of cognitive and scholastic abilities, 
such as reading and maths35–41. While it is not possible to fully disentangle input and processing problems within 
the visual stream, concurrent examination of different levels of visual processing and their relationships will help 
to better characterise the type of impairment experienced by young OPG patients.
An additional aim of the present study was to determine if clinical and socio-demographic characteristics 
are associated with neuropsychological abilities among children with history of OPG. Fouladi and colleagues13 
argued that the OPG itself is responsible for cognitive impairment, as they found similar cognitive impairment 
at diagnosis and decline over time in children with and without NF1; however another study showed that young 
patients with NF1 co-diagnosis underperformed on many cognitive indices compared to non-NF1 patients14. 
Based on the literature of childhood brain tumour, younger age at diagnosis is associated with worst cognitive 
outcomes13,42,43 but adaptive compensatory mechanisms of superior verbal-auditory skills might also occur in 
vision-related tumours44. Finally, high socio-economic status (SES) is a protective factor for intellectual and scho-
lastic45 development, whereas evidence is mixed regarding outcome status across male42 or female43 patients, 
which may be further influenced by the NF1 comorbidity46. To date, these factors have only been partially inves-
tigated in children with OPG14. While OPG can be considered relatively favourable tumours, identifying factors 
that increase risk of neuropsychological sequalae will enable more targeted intervention to be developed.
Overall, this study reports the development of visuo-perceptual, intellectual and scholastic abilities in 12 chil-
dren with OPG (with and without NF1) managed with chemotherapy or observation. The objectives were to 
explore: (1) the extent of impairment in visual perception, intellectual function and scholastic attainment, (2) the 
associations across these three domains and (3) the relationships with clinical and socio-demographic factors.
Methods
Participants. This cross-sectional study was part of a project investigating neuroimaging predictors of cog-
nitive outcomes in young brain cancer survivors. Potential participants were identified through NHS registers 
of children treated or referred to the Queen’s Medical Centre (Nottingham UK) between 2006 and 2017. Only 
children with diagnosis of tumour in the optic pathway are reported in this study. Additional inclusion criteria 
were: (i) age between 6 and 16 years, (ii) off-treatment for at least 6 months. Ethical approval was granted from 
the NHS Camberwell St Giles Research Ethics Committee and all procedures were performed in accordance with 
the Helsinki declaration. Written informed parental consent and child assent were obtained for each participant 
prior to participation.
Vision examination. Children underwent a routine ophthalmologic examination at a tertiary referral paedi-
atric neurosciences center. Visual acuity (VA) was measured through an age- and literacy-appropriate test, either 
the Bailey-Lovie test47, Crowded Kay Picture test48 or Keeler LogMAR Crowded acuity test49. VA scores of each 
eye were reported in logMAR scale and VA scores of each pair of eyes were classified using the criteria of the 2014 
SIOP-e NF1 OPG Nottingham Workshop50.
Neuropsychological assessment. Neuropsychological outcomes were assessed through standardised 
tests used widely in clinical and research work. Before study commencement, each subtest was reviewed to deter-
mine if it required vision (i.e. it cannot be completed with eyes closed), fine motor response (i.e. it requires the 
child to draw or write) and timed performance (i.e. the child is asked to perform as quickly as possible). See 
Supplementary Table S1.
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Visuo-perceptual skills were assessed using the Developmental Test of Visual Perception, either 2nd edition 
(DTVP-II;51 for ages 4–10 years) or Adolescent and Adult edition (DTVP-A;52 for ages 11–74 years). These tests 
consist of 8 and 6 subtests respectively and provide two analogous indices: Motor-Reduced Perception and 
Visual-Motor Integration. Tasks of both indices rely on vision, but only Visual-Motor Integration requires fine 
motor skills mainly with untimed performance. A composite index of General Vision Perception was obtained.
Cognitive abilities were evaluated with the Wechsler Intelligence Scale for Children, 4th UK edition 
(WISC-IVUK53; for ages 6–16 years). It consists of 10 core subtests that provide four indices of broader abilities: 
Verbal Comprehension, Perceptual Reasoning, Working Memory and Processing Speed. Verbal Comprehension 
and Working Memory involve verbal-auditory input and output; Perceptual Reasoning and Processing Speed rely 
on vision, with Processing Speed requiring fine motor skills and timed performance. Two composite indices were 
obtained: Full-Scale IQ which is based on all four individual indices, and General Ability index which is based on 
Verbal Comprehension and Perceptual Reasoning.
Scholastic attainment was assessed using the Wechsler Individual Achievement Test, 2nd UK edition 
(WIAT-IIUK54; for ages 4–16 years). It consists of 10 core subtests that provide four indices of broader academic 
abilities: Reading, Mathematics, Written Language and Oral Language. All indices rely on vision, but only 
Mathematics and Written Language require fine motor response. A Total Composite index was obtained.
The neuropsychological assessment was conducted in a quiet area at the child’s home over one to three ses-
sions, within four consecutive weeks. All children wore their glasses, if prescribed. For subtests that required 
vision, children with moderate or severe visual impairment were allowed to hold print material close for tasks that 
required a fine motor response (regardless of the timing) and to use their own magnifier device for motor-free 
subtests. No adaptation was used with children with monocular/binocular normal vision or mild visual impair-
ment (best corrected VA ≥ 0.50 logMAR score) to minimise disruption of standardised procedures.
Neuropsychological performance was scored following the test manuals and raw scores were transformed 
into standard scores (μ = 100, σ = 15) for each index. Scores were classified as: clinical impairment (below 
-2 SD), deficit (−1 to −2 SD), average (−1 to +1 SD), above-average (+1 to +2 SD) and gifted (above +2 SD). 
Socio-economic status (SES) was estimated through postcodes using the Income Deprivation Affecting Children 
Index rank 201555. Values range from 1 to 32,482, with lower scores indicating more disadvantaged areas.
Statistical analyses. Analyses were conducted in R (version 3.5.0)56 through R Studio (version 1.1.456)57. 
Sample biases were assessed comparing eligible patients who did and did not participate in terms of age, sex and 
NF1 comorbidity through independent-sample t-tests and chi-square tests. Chi-square tests with Fisher’s exact 
correction were used to assess differences between sporadic and syndromic OPGs on socio-demographic and 
clinical characteristics. All individual and composite indices were analysed using one-sample t-tests to assess 
deviations from the test norms. For comparison with previous research14, at the cognitive level, paired-sample and 
independent-sample t-tests were conducted with Verbal Comprehension, Perceptual Reasoning and Full-Scale 
IQ to investigate discrepancies across indices and differences between sporadic and syndromic cases for these 
measures. Confidence intervals at 95% level were computed and effect sizes were estimated as Cohen’s d58.
Pearson correlations were conducted to examine the associations across the three domains. Finally, several 
socio-demographic and clinical factors in relation to neuropsychological outcomes were considered. Associations 
with sex (1: female, 2: male), tumour type (1: sporadic, 2: syndromic) and visual function (1: poor, requiring visual 
aids, 2: good, not requiring visual aids) were examined using point-biserial correlations. The relationship with 
visual acuity (VA in the best eye) and SES was evaluated using Spearman’s ρ correlations. Pearson’s r correlations 
were conducted to examine the impact of age at diagnosis and time post treatment on OPG outcomes. All correla-
tion analyses were conducted on composite indices and Bonferroni correction was applied (α = 0.05/4 = 0.0125). 
Further correlations using individual indices were explored with the same alpha level of 0.0125.
Results
Sample characteristics. Of 27 eligible patients with OPG, 12 agreed to take part. Participating and 
non-participating children did not differ in age at diagnosis (t = 1.08, P = 0.292), sex (χ2 = 1.50, P = 0.398) and 
NF1 co-diagnosis (χ2 = 0.49, P = 0.683). There were 7 boys and 5 girls; 7 children (4 boys) had co-diagnosis of 
NF1. SES ranged from 8,498 to 32,309 (Mdn = 25,242.5). Mean age at assessment was 10.1 years (SD = 2.2; range: 
6.2 – 13.7); all were diagnosed with OPG before 6 years of age (M (SD) = 2.5 (1.6); range: 0.7 – 5.6). Three chil-
dren did not receive treatment for OPG; the others received chemotherapy. There were no significant differ-
ences between sporadic and NF1-associated OPGs in terms of sex (χ2 = 0.01, P = 1.00) and treatment (χ2 = 0.11, 
P = 1.00).
Visual function. Figure 1 portrays visual function of the participants. Five children had visual impairment 
(moderate 1/12, 8%; severe 4/12, 33%) and used low vision aids during the neuropsychological assessments. 
Among the other children, 1/12 (8%) had mild visual impairment, 4/12 (33%) had binocular normal vision, and 
2/12 (17%) had normal vision in the best eye with no perception of light in the worst eye. There were no differ-
ences in visual aid use between sporadic and NF1 cases (χ2 = 1.19, P = 0.558).
Neuropsychological outcomes: extent of impairment. Two children did not complete the cognitive 
and scholastic tests due to fatigue at sustaining multiple sessions. Table 1 summarises individual and group results 
for the neuropsychological assessments. Figure 2 reports group means and comparisons to test norms.
For visual perception, a significant difference from test norms was found for both individual indi-
ces Motor-Reduced Perception and Visual-Motor Integration, and for the composite index General Visual 
Perception.
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For intellectual function, there was a significant difference from test norms for Full-Scale IQ, but not General 
Ability. Scores for Working Memory and Processing Speed were significantly depressed compared to test norms. 
No significant differences were found between Verbal Comprehension and Perceptual Reasoning (t9 = 0.58, 
P = 0.577). No significant differences were found between syndromic and sporadic cases for either Full-Scale IQ 
(82.6 VS 93.8; P = 0.120), Verbal Comprehension (88.6 VS 94.4; P = 0.537), or Perceptual Reasoning (89.0 VS. 
102.0; P = 0.245).
For scholastic achievement, a deviation from test norms was found for two abilities, Written Language and 
Oral Language, but not the Total Composite index.
Neuropsychological outcomes: associations across domains. Table 2 shows associations between 
all the neuropsychological indices. Across domains, strong correlations for composite indices were found 
between scholastic attainment and cognitive functioning (both Full-Scale IQ and General Ability; r ≥ 0.85, 
P ≤ 0.002), whereas no significant correlations were found for visual perception. On individual indices, one 
medium-to-strong correlation was found between the perception index of Visual-Motor Integration and the 
visuo-spatial cognitive index of Processing Speed (r = 0.68, P = 0.031), but none between perception and aca-
demic attainment. Several moderate-to-strong correlations were found between individual indices of cognitive 
and scholastic abilities (r ≥ 0.65, P ≤ 0.043).
Impact of clinical and socio-demographic factors. Table 3 shows the relationship of neuropsycho-
logical outcomes with clinical and socio-demographic factors. Visual function was significantly associated with 
Perceptual Reasoning, Processing Speed and Written Language (all P < 0.05), demonstrating worse performance 
in children with poor vision requiring low vision aids compared to those with sufficiently intact vision (although 
Figure 1. Classification of the visual acuity scores of the best (x-axis) and worst (y-axis) eyes of each study 
participant, either with sporadic (circles) or syndromic (triangles) OPG. Children were grouped into five 
categories: binocular normal vision (green), monocular normal vision (grey), mild visual impairment (yellow), 
moderate visual impairment (orange) and severe visual impairment (red). VA = visual acuity; VI = visual 
impairment; NLP = no light perception.
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these did not survive Bonferroni correction). The other clinical and socio-demographic factors did not correlate 
significantly with neuropsychological outcomes. The direction of the effects was mixed for all variables except 
for the NF1 status, indicating that children with sporadic OPG consistently obtained lower scores on all indices 
(Supplementary Table S2).
Discussion
This is the first study documenting low-level visual acuity, high-level visual perception, verbal and visuo-spatial 
intellectual function and real-life scholastic abilities in children with OPG managed with observation or 
chemotherapy.
Case NF1 Visual function Aid
Visual perception Cognitive function Scholastic attainment
MRP VMI GVP VC PR WM PS FSIQ GA R M WL OL TC
P1 Yes Normal No A A A A A – A A A A A − A −
P2 Yes M – Normal No — — — — — — A A – A A A A + A A A
P3 Yes Normal No A A A A A A A A A A A A A A
P4 Yes Moderate VI Yes − — — — — A — — − — — — — − — — — — — − — —
P5 Yes Normal No − — — − n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t.
P6 Yes Normal No A A A n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t. n. t.
P7 Yes Severe VI Yes — — − − — — A − − − − − − − — — −
P8 No M – Normal No A A A − + A A A A A A A − A
P9 No Mild VI No A A A A A A A A A A A A A A
P10 No Severe VI Yes − — — — — + A A A A A A  + + A A +
P11 No Severe VI Yes − — — — — A A A — — A A A A − A A
P12 No Severe VI Yes A A A A − A A − − A A A − A
M 87.4* 83.5* 84.5* 91.5 95.5 85.4* 87.5* 88.2* 93.0 93.8 98.8 89.0* 88.5* 91.4
SD 14.0 17.8 15.8 13.7 16.9 8.9 15.0 11.3 11.8 13.2 18.6 13.5 14.2 14.0
Table 1. Individual profile of neuropsychological performance of the study participants on individual and 
composite indices; group statistics (mean and standard deviation) compared to test norms given below. 
MRP = Motor-Reduced Perception; VMI = Visual-Motor Integration; GVP = General Visual Perception; 
VC = Verbal Comprehension; PR = Perceptual Reasoning; WM = Working Memory; PS = Processing Speed; 
FSIQ = Full-Scale IQ; GA = General Ability; R = Reading; M = Mathematics; WL = Written Language; 
OL = Oral Language; TC = Total Composite. Visual function: VI = Visual Impairment, M = Monocular vision. 
Scores: “A” = between + 1 and −1 SD; “−” = between −1 and −2 SD.; “— —” = below −2SD.; “+” = between 
+ 1 and + 2 SD; “++” = above + 2 SD; “n. t.” = not tested. *P < 0.05 at least.
Figure 2. (A) Descriptive statistics (M and 95% CI) and results of the one-sample t-tests (t statistic, P values 
and Cohen’s d). (B) Mean (dot) and 95% confidence interval (error bar) of each test (individual and composite 
indices). Vertical red lines represent test norms: mean (solid), 1 standard deviation (dashed) and 2 standard 
deviation (dotted). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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Analyses of individual profiles showed visual perception was the most affected area, with half of the sample 
underperforming. For intellectual function and academic attainment, most children performed on average for 
each domain. Neuropsychological outcomes displayed a high degree of heterogeneity and complex relationships 
with visual impairment and NF1 co-diagnosis. Of note, three children (two sporadic cases) performed at or above 
average for some indices, whereas two children with moderate or severe visual impairment and co-diagnosis of 
NF1 (treated with chemotherapy) performed below average on almost all abilities. This result corroborates find-
ings from a previous case series describing cognitive deterioration after chemotherapy only in 3 children with 
NF1-associated OPG, who also had very poor vision at diagnosis18. At the group level, none of the indices were 
clinically impaired (≤ −2 SD), but all mean scores were in the lower range of average performance or just below 
Visual perception Cognitive functioning Scholastic attainment
MRP VMI GVP VC PR WM PS FSIQ GA R M WL OL TC
MRP —
VMI 0.72** —
GVP 0.91*** 0.94*** —
VC 0.14 −0.38 −0.16 —
PR 0.58 0.38 0.50 −0.01 —
WM 0.62 0.38 0.52 0.39 0.15 —
PS 0.53 0.68* 0.65* −0.08 0.74* 0.32 —
FSIQ 0.65* 0.30 0.48 0.53 0.76* 0.57 0.73* —
GA 0.53 0.02 0.26 0.68* 0.72* 0.39 0.49 0.93*** —
R 0.56 0.22 0.38 0.56 0.60 0.71* 0.65* 0.94*** 0.84***
M −0.05 −0.22 −0.17 0.54 0.41 0.29 0.51 0.70* 0.68* 0.77** —
WL 0.54 0.58 0.59 0.18 0.61 0.55 0.92*** 0.81** 0.58 0.80** 0.60 —
OL 0.27 −0.14 0.03 0.84** 0.42 0.35 0.34 0.79** 0.89*** 0.75* 0.73* 0.54 —
TC 0.37 0.10 0.22 0.63 0.55 0.56 0.66* 0.92*** 0.85** 0.96*** 0.89*** 0.81** 0.85** —
Table 2. Pearson’s r coefficients for the correlations between all the neuropsychological measures. 
MRP = Motor-Reduced Perception; VMI = Visual-Motor Integration; GVP = General Visual Perception; 
VC = Verbal Comprehension; PR = Perceptual Reasoning; WM = Working Memory; PS = Processing Speed; 
FSIQ = Full-Scale IQ; GA = General Ability; R = Reading; M = Mathematics; WL = Written Language; 
OL = Oral Language; TC = Total Composite. Significance at uncorrected p values: *P ≤ 0.05, **P ≤ 0.01, 















MRP −0.36 0.52 −0.47 0.37 −0.05 −0.06 −0.18
VMI −0.07 0.50 −0.47 0.31 −0.49 −0.40 −0.07
GVP −0.21 0.54 −0.48 0.36 −0.34 −0.27 −0.22
Cognitive functioning
VC −0.22 −0.02 0.17 < −0.01 0.58 0.25 0.45
PR −0.41 0.64* −0.46 0.38 0.25 0.57 0.18
WM −0.55 0.07 0.15 −0.26 0.55 −0.33 0.12
PS −0.29 0.67* −0.63* 0.22 0.04 0.08 0.23
FSIQ −0.52 0.52 −0.40 0.19 0.56 0.36 0.36
GA −0.47 0.45 −0.23 0.28 0.60 0.59 0.22
Scholastic attainment
R −0.64* 0.29 −0.10 −0.03 0.61 0.27 0.13
M −0.44 0.07 0.15 −0.25 0.71 0.43 0.54
WL −0.26 0.64* −0.61 0.20 0.18 0.03 0.29
OL −0.23 0.39 −0.27 0.27 0.63 0.53 0.61
TC −0.50 0.33 −0.21 < 0.01 0.63 0.35 0.37
Table 3. Correlations (point-biserial coefficient rpb, Spearman’s ρ, Pearson’s r) across the neuropsychological 
indices of visual perception, cognitive function and scholastic attainment in relation to clinical and socio-
demographic factors. Note: tumour type (1: sporadic, 2: syndromic), visual function (1: poor, requiring 
visual aids, 2: good, not requiring visual aids) and sex (1: female, 2: male). VA = visual acuity; MRP = Motor-
Reduced Perception; VMI = Visual-Motor Integration; GVP = General Visual Perception; VC = Verbal 
Comprehension; PR = Perceptual Reasoning; WM = Working Memory; PS = Processing Speed; FSIQ = Full-
Scale IQ; GA = General Ability; R = Reading; M = Mathematics; WL = Written Language; OL = Oral Language; 
TC = Total Composite. *Significant correlations at uncorrected P ≤ 0.05; none survived at corrected α = 0.0125.
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−1SD. The underperformance in comparison to the test norm μ = 100 was statistically significant for more than 
half of the indices (2/4 composite and 6/10 individual indices).
Visual perception was found to be a marked area of weakness in paediatric OPG patients as group perfor-
mance of all measures was significantly below the test mean. Difficulties with processing visual-perceptual stim-
uli, even without motoric response and after low vision adjustment, raise questions about the reliability of visual 
acuity tests in these patients59, when children are required to analyse the physical properties of a stimulus to 
recognise and name a shape or letter without meaningful context. Visual-perceptual processing and visual-motor 
integration were altered in children with low vision60, and weaknesses in these areas are also well established 
among NF1 children6,7,31. Our small sample did not afford the relative contribution of visual function and NF1 
status to be elucidated. However, these results indicate that visual perception should be incorporated into clinical 
assessments of children with OPG.
Amongst composite indices of intellectual function, the mean score of General Ability did not differ from test 
norms, whereas the mean score of Full-Scale IQ was significantly below. General Ability comprises only of Verbal 
Comprehension and Perceptual Reasoning, both of which were preserved. In contrast, Full-Scale IQ also includes 
Working Memory and Processing Speed, which showed significant weaknesses in our sample. Therefore, the dis-
crepancy between average General Ability and statistically-reduced Full-Scale IQ demonstrates the weaknesses in 
Working Memory and Processing Speed, which reflects the proficiency and efficiency of cognitive processing61. 
A similar pattern of results was found in a heterogeneous group of young brain tumour survivors62, where all 
children received radiation therapy and all cognitive measures were below the test mean. Our study provides 
promising results for non-irradiated OPG patients as it demonstrates that core verbal and visuo-spatial reasoning 
abilities remain intact in these children. Nonetheless, the deficit shown on general intelligence when Working 
Memory and Processing Speed are considered indicates that these two cognitive domains require clinical atten-
tion as they are critical for intellectual development63–65 and scholastic progression66,67.
At the cognitive level, there was no discrepancy between Verbal Comprehension and Perceptual Reasoning, 
and both mean scores were close to the test norm. Previous research by Lacaze and colleagues14 reported a signif-
icant difference between intact verbal IQ and depressed performance IQ (analogous indices in the WISC-III), but 
their results were confounded by the presence of irradiated children in their sample and the lack of control over 
visual input during neuropsychological assessment. On the contrary, our study with non-irradiated OPG patients 
demonstrated similar development of Verbal Comprehension and Perceptual Reasoning when children use visual 
magnifiers. This ecological approach, which is in line with the recommendations of the Brain Tumour Quality 
of Survival Group, International Society of Paediatric Oncology (Europe)24, showed that when visual stimuli are 
made accessible, visuo-perceptual reasoning in children with OPG develops adequately for the child’s age and is 
similar to their verbal comprehension skills. In addition, compared to Lacaze and colleagues14, our study showed 
no differences between sporadic and syndromic cases not only on verbal IQ measure, but on visual-spatial and 
total IQ scores. Although these novel results could arise from the adaptation of visual input, subgroup mean 
scores support a tendency towards better performance in children with sporadic OPGs compared to those with 
NF1 co-diagnosis. Of note, these analyses were conducted only for replication purpose, systematic investigation 
with larger samples is warranted in future.
Our results revealed relatively preserved scholastic attainment compared to other domains, with some chil-
dren performing above average on some measures. Children with OPG had appropriate scholastic attainment 
based on the Total Composite index and this was also confirmed on the individual indices of Reading and 
Mathematics. Mild impairment was found only in Written Language and Oral Language. Underperformance 
on Written Language might be attributable to visual-motor and handwriting difficulties, but also spelling deficits 
that can result from either low vision68,69 or NF1 syndrome70,71. The impairment in Oral Language might reflect 
difficulties at processing fine details of visual stimuli necessary for many of these tasks.
Across domains, significant associations between composite indices of visual perception and cognitive and 
scholastic abilities were not found. However, some moderate-to-strong correlations emerged for individual indi-
ces across domains that rely on vision and/or fine motor response, although these did not reach statistical signif-
icance (for example, between Motor-Reduced Perception and Perceptual Reasoning and between Visual-Motor 
Integration and Written Language), probably because of the small sample size. Therefore, associations/dissocia-
tions across these three domains should be explored further in larger studies before excluding the potential utility 
of visual rehabilitation programs for these patients.
Finally, among the clinical and socio-demographic factors, visual function showed medium-to-strong pos-
itive correlations with some cognitive and scholastic individual indices that were assessed with visual tasks. 
Consistently, VA in the best eye was negatively correlated with Processing Speed. This demonstrates that, even if 
children with poor vision were allowed low vision aids, their performance was significantly poorer in compar-
ison to the children with relatively intact vision. It has been proposed that early visual loss may either hamper 
neuropsychological acquisition causing long-term detrimental effects, or facilitate timely neural re-organisation 
and behavioural adaptation resulting in adequate development12. Our results support the first proposition as 
children with poor visual function obtained lower scores on neuropsychological tests despite the use of low visual 
aids. This is consistent with results in adulthood reporting poor neurocognitive outcomes in low-grade glioma 
survivors with bilateral blindness compared to those without visual impairment12. Notably, NF1 demonstrated 
a consistent effect on all neuropsychological abilities, with syndromic cases underperforming in comparison 
to sporadic cases, although this was statistically significant only for Reading. This is consistent with findings by 
Lacaze and colleagues14, who also compared children with and without NF1 treated with front-line chemother-
apy. While NF1 research tends to exclude patients with OPG due to brain abnormality or visual impairment, the 
results of this study suggests that overall deficits associated with OPG might be driven by NF1 co-diagnosis and 
therefore these children require more research and clinical attention, although there is a desperate need for relia-
ble and standardised tools to evaluate visually impaired children72.
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Strengths of this study include utilisation of comprehensive standardised tests (with high internal consistency 
across individual subtests) for each domain, the ecological use of low vision aids to address vision input at least 
in motor-free tasks, and the exclusion of neurotoxic effects due to radiation. The main limitation is low statistical 
power due to the small sample size, which increases the risk of false negative results. This was also a limitation of 
the only other previous report of neuropsychological sequelae of OPG which has additional critical confound-
ers14. Our findings suggest that assessment of visual-perceptual processing, a marked weakness of OPG patients, 
should be included during routine ophthalmologic examinations. Future research could investigate differences 
between OPG patients with and without NF1 using a larger sample, and control for adaptations to visual materi-
als, to elucidate the impact of vision loss on neuropsychological outcomes beyond information input.
Data availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.
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